BioSpace News Archive

Business

PerkinElmer to Hold Earnings Call on Monday, January 27, 2020

PerkinElmer, Inc. announced that on Monday, January 27, 2020, after market close, the Company will release fourth quarter 2019 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results.

January 7, 2020
·
1 min read
Biotech Beach

Puma Biotechnology to Present at the J.P. Morgan Healthcare Conference

Puma Biotechnology, Inc., a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 12:00 p.m. PST on Wednesday, January 15, at the 38th Annual J.P. Morgan Healthcare Conference.

January 7, 2020
·
1 min read
Biotech Bay

Exelixis to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020

Exelixis, Inc. announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide a corporate overview at the 38th Annual J.P. Morgan Healthcare Conference being held next week in San Francisco.

January 7, 2020
·
2 min read
Theravance Biopharma Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will webcast its presentation at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020.

January 7, 2020
·
2 min read
Biotech Bay

Personalis, Inc. Announces the Launch of the NeXT Dx™ Test, a Comprehensive Genomic Cancer Profiling Test Enabling Advanced Composite Biomarkers for Cancer Treatment

Personalis, Inc., a leader in advanced genomics for cancer, announced the launch of the NeXT Dx™ Test to help oncologists identify potential therapies and clinical trial options for cancer patients.

January 7, 2020
·
4 min read
Business

Sirnaomics and Innovent Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining STP705 and Sintilimab in the US

This collaborative effort between Sirnaomics and Innovent will be the first example of a combination strategy using an RNAi drug candidate together with an approved immune checkpoint antibody drug for the treatment of liver cancers.

January 7, 2020
·
7 min read
Biotech Bay

SeaSpine Prices Public Offering of Common Stock

The offering is expected to close on or about January 10, 2020, subject to customary closing conditions.

January 7, 2020
·
6 min read
Policy

Federal Court Vacates Judgment in IVC Filter Litigation Case, Cook Medical Continues Fight for Physician Access to Life-Saving Filter Technology

The Court also ordered a new trial.

January 7, 2020
·
2 min read
Eisai’s Fycompa for Adjunctive Treatment of Partial Onset Seizures Launched in China

In China, it is estimated that there are approximately 9 million patients with epilepsy, approximately 60% of whom are affected by partial-onset seizures.

January 7, 2020
·
5 min read
Deals

Intra-Cellular Therapies Prices Public Offering of Common Stock at $29.50 per share

Intra-Cellular Therapies, Inc. announced the pricing of its previously announced underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $29.50 per share.

January 7, 2020
·
2 min read